The potential of inhaled drug delivery goes beyond traditional respiratory medicine.

Are you compliant with the new guidelines for elemental impurities? There’s only six months left to get up to speed.

If pharma wants to adopt continuous manufacturing, it must employ control procedures to ensure quality.

With approximately 80 percent of new drugs suffering from poor solubility and bioavailability, understanding solid form is more important than ever.

Joint letter from eight trade associations warns of “supply disruptions to life-saving medicines.”

A small-molecule drug has shown its ability to diminish HIV reservoirs.

High-throughput excipient discovery looks set to boost oral bioavailability.

The FDA aims to reduce drug prices with a more competitive market - and generics are key.

Will pharma adopt distributed ledger technology for data management within the next five years?

Multistep continuous-flow manufacturing is easier said than done. But Eli Lilly has found a way…